ZA200206343B - Use of pyrimidine endothelin antagonists in companion animals. - Google Patents

Use of pyrimidine endothelin antagonists in companion animals.

Info

Publication number
ZA200206343B
ZA200206343B ZA200206343A ZA200206343A ZA200206343B ZA 200206343 B ZA200206343 B ZA 200206343B ZA 200206343 A ZA200206343 A ZA 200206343A ZA 200206343 A ZA200206343 A ZA 200206343A ZA 200206343 B ZA200206343 B ZA 200206343B
Authority
ZA
South Africa
Prior art keywords
companion animals
pyrimidine
endothelin antagonists
endothelin
antagonists
Prior art date
Application number
ZA200206343A
Other languages
English (en)
Inventor
Banks Bernard Joseph
Foster Adrian Paul
Gibson Stephen Paul
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200206343B publication Critical patent/ZA200206343B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
ZA200206343A 2000-02-11 2002-08-08 Use of pyrimidine endothelin antagonists in companion animals. ZA200206343B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment

Publications (1)

Publication Number Publication Date
ZA200206343B true ZA200206343B (en) 2003-08-08

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200206343A ZA200206343B (en) 2000-02-11 2002-08-08 Use of pyrimidine endothelin antagonists in companion animals.

Country Status (17)

Country Link
EP (1) EP1254120B1 (tr)
JP (1) JP2003528050A (tr)
KR (1) KR20020075791A (tr)
AT (1) ATE271042T1 (tr)
AU (1) AU3043601A (tr)
CA (1) CA2398007A1 (tr)
DE (1) DE60104283T2 (tr)
DK (1) DK1254120T3 (tr)
ES (1) ES2222975T3 (tr)
GB (1) GB0003234D0 (tr)
HU (1) HUP0204370A3 (tr)
IL (1) IL150488A0 (tr)
NZ (1) NZ519002A (tr)
PT (1) PT1254120E (tr)
TR (1) TR200401815T4 (tr)
WO (1) WO2001058882A1 (tr)
ZA (1) ZA200206343B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
CN101198259B (zh) * 2005-04-19 2014-05-28 希尔氏宠物营养品公司 用于预防和治疗肾脏疾病的方法和组合物
RU2573505C2 (ru) * 2010-02-25 2016-01-20 Ф.Хоффманн-Ля Рош Аг Способ определения константы связывания высокоаффинных соединений

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2172735C2 (ru) * 1995-12-20 2001-08-27 Яманоути Фармасьютикал Ко., Лтд. Арилэтенсульфонамидные производные и фармацевтическая композиция
WO1998057938A1 (fr) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Derives d'alcanesulfonamide inferieur substitue et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
KR20020075791A (ko) 2002-10-05
IL150488A0 (en) 2002-12-01
NZ519002A (en) 2004-06-25
EP1254120B1 (en) 2004-07-14
GB0003234D0 (en) 2000-04-05
JP2003528050A (ja) 2003-09-24
DE60104283D1 (de) 2004-08-19
ATE271042T1 (de) 2004-07-15
HUP0204370A3 (en) 2003-07-28
EP1254120A1 (en) 2002-11-06
HUP0204370A2 (en) 2003-05-28
PT1254120E (pt) 2004-10-29
CA2398007A1 (en) 2001-08-16
DK1254120T3 (da) 2004-10-04
ES2222975T3 (es) 2005-02-16
TR200401815T4 (tr) 2004-08-23
WO2001058882A1 (en) 2001-08-16
DE60104283T2 (de) 2004-11-18
AU3043601A (en) 2001-08-20

Similar Documents

Publication Publication Date Title
DK1257175T3 (da) Brug af syrestabile Subtilisin Proteaser i dyrefoder.
ID28812A (id) Enzima-enzima antimikroba di dalam pakan hewan
GB0209891D0 (en) Novel compounds
TR200102839T2 (tr) LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler.
AU2003217974A8 (en) Hoofed animal pad
CA2373499A1 (en) Use of creatine as feed additive
AU149714S (en) Animal puppy chew
YU82503A (sh) Upotreba antagonista neuronskih natrijumovih kanala za kontrolu ektoparazita kod toplokrvnih životinja
IT1312325B1 (it) Microgranulo per l'alimentazione animale, particolarmente idoneo perintegrare mangimi con sali di calcio.
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
ZA200206343B (en) Use of pyrimidine endothelin antagonists in companion animals.
DE60202669D1 (de) 6-phenylbenzonaphthyidine
MXPA03008681A (es) (oxo-pirazol[1,5]pirimidin-2-il)alquil-carboxamidas.
WO2000075119A3 (de) Substituierte 2-aryl-1,2,4-triazin-3,5-di(thi)one als herbizide
LU90560B1 (fr) B-timent d'-levage d'animaux - ventelles
AU2000251168A1 (en) Feed additives, forage and agents for animals, methods for the use thereof
RU2001115463A (ru) Стимулятор воспроизводительной способности самок пушных зверей и жизнеспособности их приплода
ES1043194Y (es) Comedero para la 1 edad de animales estabulados.
RU2002135882A (ru) Кормовая добавка для молодняка крупного рогатого скота
RU2002102828A (ru) Этиловый эфир 5-бром-3,4-дигидрокси-2-карбамоил-6-оксо-6-фенил-2,4-гексадиеновой кислоты, проявляющий антимикробную активность
IT1318718B1 (it) Batteria per l'allevamento di avicoli o di altri animali daallevamento
Shipilov et al. Tectonic and geodynamic evolution of the Lomonosov ridge
RU2001105594A (ru) Кормовая добавка
RU2000100516A (ru) 5(3)-фенил-4-фенилазо-3(5)-пиразол карбоновая кислота, проявляющая антимикробную активность
ES1048675Y (es) Comedero perfeccionado, para alimentar animales.